Latest Articles
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial - Yahoo Finance
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial Yahoo Finance
Published: July 27, 2026, 10:08 p.m.
Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer - RSVP Live
Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer RSVP Live
Published: July 24, 2026, 6:04 p.m.
FOSL2-driven SASP in endometrial stroma promotes the inflammation of endometriosis - Nature
FOSL2-driven SASP in endometrial stroma promotes the inflammation of endometriosis Nature
Published: July 24, 2026, 5:37 a.m.
PIEZO1-mediated endometrial decidualization is disrupted in miscarriage through BECN1-dependent autophagy - Nature
PIEZO1-mediated endometrial decidualization is disrupted in miscarriage through BECN1-dependent autophagy Nature
Published: July 23, 2026, 1:01 a.m.
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators - Escuela Andaluza de Salud Pública
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Escuela Andaluza de Salud Pública
Published: July 22, 2026, 9:19 a.m.
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial - BioPharm International
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial BioPharm International
Published: July 16, 2026, 9:06 p.m.
Endometrial Ablation Devices Market size to Reach USD 1.62 - openPR.com
Endometrial Ablation Devices Market size to Reach USD 1.62 openPR.com
Published: July 16, 2026, 5:35 p.m.
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily
Published: July 16, 2026, 4:40 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm
Published: July 16, 2026, 10:27 a.m.
Link copied to clipboard!